Wai K. Seto - Publications

Regression of liver fibrosis after seroclearance of hepatitis B surface antigen: a prospective matched case-control study using transient elastography and serum Enhanced Liver Fibrosis test (abridged secondary publication).

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: January 02, 2025

Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 30, 2024

Effect of metabolic dysfunction-associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant.

Journal: Journal of gastroenterology and hepatology

Published: April 29, 2024

Development and validation of HBV surveillance models using big data and machine learning.

Journal: Annals of medicine

Published: February 10, 2024

Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial.

Journal: Hepatology (Baltimore, Md.)

Published: December 04, 2023

Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 02, 2023

Endocuff With or Without Artificial Intelligence-Assisted Colonoscopy in Detection of Colorectal Adenoma: A Randomized Colonoscopy Trial.

Journal: The American journal of gastroenterology

Published: October 11, 2023

Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study.

Journal: BMC gastroenterology

Published: July 06, 2023

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

Journal: JHEP reports : innovation in hepatology

Published: March 23, 2023

Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients.

Journal: Journal of gastroenterology and hepatology

Published: February 20, 2023

Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients.

Journal: Vaccines

Published: January 13, 2023

The role of different viral biomarkers on the management of chronic hepatitis B.

Journal: Clinical and molecular hepatology

Published: December 14, 2022